FOTEMUSTINE IN PATIENTS WITH RELAPSING MALIGNANT GLIOMAS - A PHASE-II TRIAL

被引：0
|
作者：
PUNT, CJA
STAMATAKIS, L
GERARD, B
机构：
[1] INST RECH INT SERV,BRUSSELS,BELGIUM
[2] CTR HOSP TIVOLI,LA LOUVIERE,BELGIUM
来源：
ONCOLOGY REPORTS | 1995年 / 2卷 / 02期
关键词：
BRAIN TUMORS; GLIOMA; ASTROCYTOMA; GLIOBLASTOMA MULTIFORME; CHEMOTHERAPY; FOTEMUSTINE;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Eleven patients with relapsing malignant glioma were treated with fotemustine chemotherapy, a new nitrosourea derivative. One partial response of 13 months duration occurred, resulting in a marked improvement of the quality of life of the patient. Seven patients had stable disease for a median duration of 5 months. Median survival from inclusion in the study was 6 months. Toxicity was mainly hematologic and manageable. We confirm that fotemustine has some activity in patients with relapsing malignant glioma.
引用
收藏
页码：307 / 308
页数：2
相关论文
共 50 条
  • [41] PHASE-II TRIAL OF CARBOPLATIN IN ADVANCED MALIGNANT-MELANOMA
    EVANS, LM
    CASPER, ES
    ROSENBLUTH, R
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 171 - 172
  • [42] A MULTICENTER PHASE-II TRIAL OF VINDESINE IN MALIGNANT-MELANOMA
    CARMICHAEL, J
    ATKINSON, RJ
    CALMAN, KC
    MACKIE, RM
    NAYSMITH, AM
    SMYTH, JF
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (12): : 1293 - 1295
  • [43] PHASE-II TRIAL OF IFOSFAMIDE IN CHILDREN WITH MALIGNANT SOLID TUMORS
    PRATT, CB
    HOROWITZ, ME
    MEYER, WH
    ETCUBANAS, E
    THOMPSON, EI
    DOUGLASS, EC
    WILIMAS, JA
    HAYES, FA
    GREEN, AA
    CANCER TREATMENT REPORTS, 1987, 71 (02): : 131 - 135
  • [44] A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas
    Jimmy Ruiz
    Doug Case
    Gina Enevold
    Robin Rosdhal
    Stephen B. Tatter
    Thomas L. Ellis
    Richard P. McQuellon
    Kevin P. McMullen
    Volker W. Stieber
    Edward G. Shaw
    Glenn J. Lesser
    Journal of Neuro-Oncology, 2012, 106 : 611 - 617
  • [45] Phase II trial of bevacizumab and irinotecan in the treatment of malignant gliomas
    Goli, K. J.
    Desjardins, A.
    Herndon, J. E., II
    Rich, J. N.
    Reardon, D. A.
    Quinn, J. A.
    Sathornsumetee, S.
    Bota, D. A.
    Friedman, H. S.
    Vredenburgh, J. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [46] PHASE-II TRIAL OF VM-26 IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA
    BELLET, RE
    CATALANO, RB
    MASTRANGELO, MJ
    BERD, D
    KOONS, LS
    CANCER TREATMENT REPORTS, 1978, 62 (03): : 445 - 447
  • [47] PHASE-II TRIAL OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH ADVANCED MALIGNANT-MELANOMA
    STANTON, G
    CASPER, ES
    FRIEDMAN, B
    CANCER TREATMENT REPORTS, 1985, 69 (7-8): : 915 - 916
  • [48] A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas
    Ruiz, Jimmy
    Case, Doug
    Enevold, Gina
    Rosdhal, Robin
    Tatter, Stephen B.
    Ellis, Thomas L.
    McQuellon, Richard P.
    McMullen, Kevin P.
    Stieber, Volker W.
    Shaw, Edward G.
    Lesser, Glenn J.
    JOURNAL OF NEURO-ONCOLOGY, 2012, 106 (03) : 611 - 617
  • [49] PHASE-II TRIAL OF CARBOPLATIN (JM8) IN TREATMENT OF PATIENTS WITH MALIGNANT MESOTHELIOMA
    MBIDDE, EK
    HARLAND, SJ
    CALVERT, AH
    SMITH, IE
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 18 (03) : 284 - 285
  • [50] PHASE-II TRIAL OF CHLOROZOTOCIN IN METASTATIC MALIGNANT-MELANOMA
    HOTH, D
    ROBICHAUD, K
    WOOLLEY, PV
    MACDONALD, JS
    PRICE, N
    GULLO, J
    SCHEIN, PS
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 413 - 413
12345